drugset / Trial / NCT00635076
A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the long-term (6-month) efficacy, safety, and tolerability of alprazolam XR in adolescents with panic disorder.
Timeline
- Start
- 2004-07
- Primary completion
- —
- Completion
- 2004-09
Outcome
Outcome not reported
Stopped: “Please see Detailed Description for the termination reason.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | alprazolam XR | Unknown | 1 mg | Oral |
| Comparator | alprazolam XR | Unknown | 2 mg | Oral |
| Comparator | alprazolam XR | Unknown | 3 mg | Oral |
| Comparator | alprazolam XR | Unknown | 4 mg | Oral |
| Comparator | alprazolam XR | Unknown | 5 mg | Oral |
| Comparator | alprazolam XR | Unknown | 6 mg | Oral |